DLA Piper's Schulman Joins Pfizer As GC
Amy Schulman, who was the lead attorney for Pfizer Inc. in the Celebrex and Bextra multidistrict litigation when she was a partner at DLA Piper, has left the firm to take...To view the full article, register now.
Already a subscriber? Click here to view full article